Literature DB >> 16497480

Inhibition of growth and increase of alkaline phosphatase activity in cultured human oral cancer cells by all-trans retinoic acid.

B Xiao1, J Guo, Y Lou, D Meng, W Zhao, L Zhang, C Yan, D Wang.   

Abstract

In this study, the effects of all-trans retinoic acid (ATRA) on human oral cancer cells with regard to cell growth, the cell cycle, and alkaline phosphatase (ALP) activity were evaluated. Human oral cancer KB cells were treated with various concentrations of ATRA, and cell growth was then determined using the MTT viability assay. The cell-cycle distribution and ALP activity were analysed using a flow cytometer and chemical analyser, respectively. The KB cells were inhibited by ATRA at concentrations of 1-16 microM (1 microM, P<0.05; 2 microM, P<0.01; 4, 8 and 16 microM, P<0.001) in a dose-dependent manner. ATRA arrested KB cells in the G0/G1 phase. The ALP activity in KB cells was increased by ATRA. This is one of the first studies to focus on the expression of ALP in human head-and-neck carcinoma cells treated with retinoids. These findings suggest that the anti-tumour effects of ATRA on human oral cancer are associated with G0/G1 phase arrest and an increase in ALP activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497480     DOI: 10.1016/j.ijom.2006.01.005

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  2 in total

Review 1.  Mitochondrial respiratory dysfunction and mutations in mitochondrial DNA in PINK1 familial parkinsonism.

Authors:  Sergio Papa; Anna Maria Sardanelli; Nazzareno Capitanio; Claudia Piccoli
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

2.  All-trans retinoic acid restores gap junctional intercellular communication between oral cancer cells with upregulation of Cx32 and Cx43 expressions in vitro.

Authors:  Juan Wang; Yaohui Dai; Yulei Huang; Xiaohua Chen; Hong Wang; Yun Hong; Juan Xia; Bin Cheng
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.